Diversity in clinical trials: Advances and areas for improvement
It is impossible to view a trial as being of high quality without adequate representation of all patient populations....
It is impossible to view a trial as being of high quality without adequate representation of all patient populations....
Accelerating clinical trial enrollment, through increased compensation, can catalyze access to much-needed medications....
In this interview, Mabel Peters, who works with the UW Clinical Research Office as a clinical trials liaison, discusses her career path, and why diverse participation is so critical to the success of clinical trials....
Shiva Bidar’s steady influence on the public and private sector’s role in developing sustainable models of diversity, equity and inclusion (DEI) hasn’t always drawn headlines, but it's garnered results....
The Circle of Trust is a new conceptual model that can help investigators and the American Indian/Alaska Natives (AI/AN) community work together to promote inclusion of AI/AN populations in clinical trials to improve health outcomes....
National Institutes of Health (NIH) representatives state that international investment, collaboration, and coordination have been key to responding to the COVID-19 pandemic....
As the first generation of Alzheimer's disease drugs hits the market, some researchers are troubled by the lack of clinical data available on the effectiveness of these drugs in Black people. ...
Experts share why protection by the exclusion of pregnant people leads to a lack of evidence-based medicine and ways to improve clinical trial conduct....
Technology that streamlines processes, provides transparency into clinical operations and enables robust data collection will empower sponsors to more rapidly enroll clinical studies and to study medicines in the diverse populations which they will serve. ...
'Social determinants of health' is used often by public health personnel, but for many people, the meaning isn't clear....